Ohio will get $5 million as part of a global settlement with drug maker Sanofi-Aventis, which was accused of cheating Medicaid on the cost of nasal sprays.
The settlement was first announced in May and totals $95.5 million. Ohio Attorney General Richard Cordray announced the state's share Friday.
The money will be paid by Aventis Pharmaceutical Inc., a wholly owned subsidiary of Sanofi-Aventis U.S. LLC.
The U.S. Justice Department charged that between 1995 and 2000, Aventis and its corporate predecessors did not offer Medicaid the best prices for the sprays Azmacort, Nasacort and Nasacort AQ.
Medicaid is a state and federally funded health care program for the poor.
In reaching the settlement, New Jersey-based Sanofi-Aventis did not admit any wrongdoing.